NCT01587027View on ClinicalTrials.gov

Safety Evaluation of Aminophylline and Methazolamide

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Mountain Sickness
Interventions
DRUG

Aminophylline

Aminophylline dosage form-tablet dosage-500mg

DRUG

Methazolamide

Methazolamide dosage form-tablet dosage-250mg

DRUG

Aminophylline and Methazolamide

Aminophylline 500mg orally and Methazolamide 250mg orally

Trial Locations (1)

80538

Medical Center of the Rockies, Loveland

All Listed Sponsors
collaborator

Defense Advanced Research Projects Agency

FED

collaborator

University of Colorado, Denver

OTHER

lead

Poudre Valley Health System

OTHER

NCT01587027 - Safety Evaluation of Aminophylline and Methazolamide | Biotech Hunter | Biotech Hunter